Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-004371

Options or other derivatives

  • Chief Medical Officer acquired 1,914,672 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Norry Elliot Chief Medical Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +1,407,072 1,407,072 D
Norry Elliot Chief Medical Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +314,256 314,256 D
Norry Elliot Chief Medical Officer 2023-01-17 Grant or award · Option to purchase Ordinary Shares +193,344 193,344 D
Loading xslF345X03/tm231655-11_4seq1.xml…